Project Grant HT94252310952
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$788K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Stony Brook, NY 11794, USA
Similar Awards
This federal Project Grant award of $841,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research performed by Exponent Inc. to assess mortality risk from exposure to the environmental contaminant beryllium and investigate associated co-morbidities. The award, effective September 30, 2023 through September 29, 2026, will fund Exponent's multi-year research project focused on exposure assessment and analysis of the health impacts...
The Defense Health Agency awarded a $250,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Materion Brush Inc., a division of Materion Corporation, to conduct research on mortality risk and co-morbidities from beryllium exposure over a 3-year period. As a global leader in advanced materials manufacturing, Materion Brush Inc. will leverage its expertise in producing beryllium and beryllium alloys to support innovative medical solutions for service...
The federal Project Grant award, titled "INNATE LYMPHOCYTE RESPONSES TO ACUTE HUMAN BABESIOSIS," provides $478,500.00 in funding to Stony Brook University under the Military Medical Research and Development program (CFDA 12.420) administered by the Defense Health Agency. The grant supports research to investigate medical solutions for conditions relevant to military personnel, with a focus on advancing understanding of acute human babesiosis, a tick-borne illness. The project is...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $325,947 Project Grant to New York University (NYU) School of Medicine on September 15, 2024. The grant supports a 3-year research project titled "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure." This funding enables NYU's research team to investigate the genomic and molecular impacts of benzene exposure, with the goal of advancing scientific...
The U.S. Department of Defense (DoD) awarded a $250,000 Project Grant to The Research Foundation For The State University Of New York, doing business as Stony Brook University, under the DoD Basic Scientific Research program (CFDA 12.431). The award, effective August 15, 2024 through August 14, 2027, will support foundational and applied research aimed at advancing scientific understanding and developing innovative capabilities with potential military applications, such as in the areas of...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,309,471 Project Grant to New York University (NYU) School of Medicine to conduct research on the "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure." The project, which spans from September 2024 to September 2027, will investigate the molecular mechanisms and genetic markers associated with benzene exposure and its relationship to cancer development. As a...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $975,210.00 to New York University (NYU) School of Medicine to conduct research on the "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure". The award period runs from September 15, 2024 to September 14, 2027. Through this funding, NYU School of Medicine will carry out innovative biomedical research investigating the genetic and...
This $124,965.57 federal Project Grant award was provided by the Department of the Army Materiel Command Research Development and Engineering Command (RDECOM) under the Department of Defense Basic Scientific Research program (CFDA 12.431). The award supports an effort to upgrade the molecular beam epitaxy (MBE) system at Stony Brook University for the development of novel mid-infrared semiconductor photonic devices. The research aims to advance fundamental knowledge and develop capabilities...
The Department of the Army Medical Command awarded $754,214 to The Research Foundation for the State University of New York at Stony Brook University under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2022 to August 31, 2025. The project aims to develop peripheral blood biomarkers to diagnose active Lyme disease and post-treatment Lyme disease syndrome. Stony Brook University will investigate medical solutions for Lyme disease diagnosis through...
This $396,569 Project Grant awarded by the Department of the Army Materiel Command Research Development and Engineering Command (RDECOM) under the Department of Defense Basic Scientific Research program (CFDA 12.431) supports foundational and applied research at Stony Brook University. The research seeks to advance fundamental knowledge and develop capabilities with potential military applications, focusing on areas such as quantum computing, artificial intelligence, robotics, advanced...